Showing results (2011-2020 of 2,375) with videos related to
Sort By:
Pageof 238
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2006
A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumorsL Gore, S N Holden, R B Cohen, et al.Cancer Chemotherapy and Pharmacology|June 4, 2011
A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumorsJ R Infante, R Kurzrock, J Spratlin, et al.Plos One|April 4, 2012
Analysis of clonal type-specific antibody reactions in Toxoplasma gondii seropositive humans from Germany by peptide-microarrayPavlo Maksimov, Johannes Zerweck, Aline Maksimov, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitorLisa J Green, Philip Marder, Chad Ray, et al.Journal of Cellular Physiology|May 12, 2006
Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinasesMaria Pia Morelli, Tina Cascone, Teresa Troiani, et al.Skeletal Radiology|March 6, 2010
Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinomaAndreas Gutzeit, Aleksis Doert, Johannes M Froehlich, et al.BMJ Open Diabetes Research & Care|August 5, 2020
Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney diseaseMeera Nair, William P Martin, Vadim Zhernovkov, et al.Transplant Immunology|October 18, 2020
Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysisMichal Pazdernik, Helena Bedanova, Zhi Chen, et al.The Oncologist|August 25, 2018
A Phase I Dose-Escalation Study of Linsitinib (OSI-906), a Small-Molecule Dual Insulin-Like Growth Factor-1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced CancerS Lindsey Davis, S Gail Eckhardt, Jennifer R Diamond, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2019
Comprehensive Genomic Landscapes in Early and Later Onset Colorectal CancerChristopher H Lieu, Erica A Golemis, Ilya G Serebriiskii, et al.Pageof 238